OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO) announces today that it has signed a feasibility agreement with a top-5 generics company to develop a generic formulation of an existing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results